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Follicular Dendritic Cells
Follicular dendritic cells signal the formation of B cell
follicles as well as B cell activation, proliferation, and
maturation. However, the precise molecular pathways
controlling these processes are just beginning to be
unraveled.
Establishment of T cell-dependent humoral immunity
requires key cell-cell interactions in the B cell follicles
of secondary and tertiary lymphoid tissues. Clusters of
follicular dendritic cells (FDCs) provide both organizing
signals for the proper structure of the follicles and reg-
ulatory signals to support B cell activation, proliferation,
and maturation. In this issue of Immunity, Victoratos
et al. underscore the requirement for tumor necrosis
factor (TNF) to activate FDCs and identify IkappaB
kinase 2 (IKK2)-dependent signaling as critical for the
expression of a fully functional germinal center B cell
response (Victoratos et al., 2006).
Properly regulated immune responses, which include
development of robust immune memory, require inter-
actions between antigen-presenting cells (APCs), effec-
tor lymphocytes, and additional regulatory cells. Effi-
cient induction of T cell-dependent immune responses
occurs largely in secondary and tertiary lymphoid tis-
sues (Karrer et al., 1997). These lymphoid tissues pro-
vide an organized environment in which naive antigen-
specific cells and antigen-nonspecific accessory cells
and regulatory cells accumulate in preparation for an
encounter with antigen. Delivery of antigens into a lym-
phoid organ causes antigen-specific T cells and B cells
to be activated and to move to new locations that facil-
itate their interactions to generate high-affinity antibody
responses and durable immune memory.
The lymphoid tissue compartment designated the B
cell follicle is central in the formation of high-affinity an-
tibody responses and B cell memory. In normal lym-
phoid organs, it is the site where the germinal center(GC) reaction develops. Although immunoglobulin gene
somatic hypermutation and selection of high-affinity an-
tibody can occur without GCs (Matsumoto et al., 1996),
intact GCs dramatically enhance the efficiency of the
high-affinity response (Le Hir et al., 1996). In lymphoid
tissues, mature FDCs play key roles as follicle orga-
nizers. When they receive the proper developmental
and maturational signals, FDCs cluster and express
the chemokine CXCL13 and adhesion molecules that
help localize cells that participate in the GC response.
Once they are clustered, FDCs express a dense network
of dendritic processes that display both complement
and Fc receptors that localize antigen-containing im-
mune complexes required for the efficient generation
and selection of high-affinity, somatically mutated anti-
bodies and for the formation of memory B cells. In addi-
tion to binding immune complexes, FDCs interact avidly
with B cells by virtue of the adhesion molecules ICAM-1
and VCAM-1 on the FDCs, which interact with LFA-1
and VLA-4 on the B cell. These physical interactions
are crucial for the survival of B cells proliferating in the
GC (Koopman et al., 1994; Tew et al., 2001). In addition
to supporting survival of GC B cells, FDCs appear to
activate both isotype switching and somatic hypermu-
tation, inducing expression of the activation-induced
cytidine deaminase (AID) in B cells that have been stim-
ulated with antigen (Aydar et al., 2005).
Considerable progress has been made in defining
signals that affect FDC differentiation and maturation.
Many studies have shown that FDCs are derived from
radio-resistant, nonhematopoietic lineage cells. The ex-
act nature of these precursor cells remains undefined.
Nevertheless, it is clear that interactions between sev-
eral ligands in the TNF family and their receptors are re-
quired for normal development of FDCs from these pre-
cursors and for normal FDC survival and function. Mice
deficient in the membrane lymphotoxin heterotrimer
(LTa1b2) or its cell-surface receptor (LTbR) manifest con-
genital absence of lymph nodes and Peyer’s patches as
well as disordered spleen structure with absence of de-
tectable FDCs (Matsumoto et al., 1996). A direct role for
LTa1b2 in FDC differentiation or activation is supported
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14Figure 1. TNF Signals Induce Formation of
Clustered FDC and with IKK2 Support Func-
tional GC B Cell Responses
In TNF-deficient mice, cells bearing FDC sur-
face markers accumulate abnormally in the
spleen white pulp marginal zone. Restoration
of TNF signaling leads to relocation of these
FDCs or immature FDC precursors to nascent
B cell follicles where the cells cluster and
form a rich dendritic network. Signaling
through the p55TNFR leads to activation of
NF-kB transcription factors via two path-
ways. The classical pathway that includes
signaling by IKK2 induces B cell resistance
to apoptosis, AID gene expression, isotype
switching, and affinity maturation. In the ab-
sence of IKK2, clusters of FDCs form that
are capable of supporting GC B cell prolifera-
tion but that poorly support isotype switch-
ing, affinity maturation, and B cell survival.by the observations that FDCs bear LTbR on their sur-
faces and that treatment of mice with soluble LTbR re-
sulted in disappearance over several days of detectable
FDCs (Mackay and Browning, 1998). This latter study
could not, however, exclude the possibility that the ef-
fect of LTa1b2-LTbR signaling was mediated indirectly
through a non-FDC cell that provided a trophic signal re-
quired by the FDC.
Mice deficient in TNF or in the p55 isoform of the TNF
receptor (p55TNFR) also show disturbed FDC matura-
tion (Le Hir et al., 1996). In this case, however, cells
bearing FDC-specific surface markers are found in the
spleen in large numbers, but inappropriately localized
in the marginal zone (Pasparakis et al., 2000). Further-
more, the adjacent B cells, without signals from clus-
tered FDCs, show no detectable follicular organization.
GCs do not form after immunization, and antibody re-
sponses and B cell memory are profoundly suppressed.
It is not known whether these marginal zone FDC-like
cells are FDC precursors or are incompletely activated
or differentiated FDCs. Interestingly, treatment of TNF-
deficient mice with an activating p55TNFR monoclonal
antibody caused rapid clustering of FDCs with the for-
mation of a rich dendritic network and restoration of the
ability to form GCs (Mandik-Nayak et al., 2001). In vivo,
the TNF signal that leads to FDC clustering and matura-
tion is thought to be delivered by follicular B cells, and
thus represents an example where the B cell provides
signals that support the development of a specialized
microenvironment in which the B cells themselves can
express their mature functions. Although FDCs bearp55TNFR on their surfaces, studies performed to date
have not determined whether TNF acts directly on the
FDC to induce their relocalization from the marginal
zone into clusters within the follicular area (Figure 1).
In fact, it is not clear whether TNF signaling occurs
solely within the marginal zone to permit transition of
the FDCs from this compartment into the follicular
areas or whether it acts at multiple locations within the
white pulp.
Victoratos et al. have taken an elegant approach to
address the question of whether p55TNFR acts in
a cell-autonomous fashion for the maturation of FDCs
(Victoratos et al., 2006). Their strategy takes advantage
of the tissue specificity of CD21 (complement receptor
2) expression to drive lineage-specific reactivation of
a Tnfr1a (encoding p55TNFR) null mutation via Cre-
loxP recombination intended to affect only FDCs. The
Tnfr1a-null mutation was created by inserting a neomy-
cin-resistance cassette flanked by upstream and down-
stream loxP sites into an intron of the Tnfr1a gene in
a fashion that completely interrupted expression of the
p55TNFR. Expression of Cre under the CD21 promoter
excises the neo cassette and restores p55TNFR expres-
sion only in cells that express CD21. Because CD21 ex-
pression is high in mature B cells and in FDCs, this strat-
egy results in mice with restored p55TNFR in mature B
cells and FDCs. To eliminate the contribution of B cell-
derived p55TNFR, CD21-reactivated mice were lethally
irradiated and transplanted with bone marrow from
Tnfr1a2/2 mice, replacing the recipient’s p55TNFR+
B cells with donor p55TNFR-deficient B cells, leaving
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ient FDCs. Mice treated in this fashion showed restora-
tion of FDC clustering in the spleen and lymph nodes
and parallel restoration of GC function, excluding a re-
quirement for p55TNFR on B cells in the activation of
FDC clustering and FDC function. CD21 is also known
to be expressed, albeit at lower amounts, in subsets
of immature thymocytes and in several epithelial tissues
(Timens et al., 1991). It is, thus, difficult to exclude com-
pletely a contribution of radio-resistant CD21+ non-FDC
to the restoration of normal FDC localization and func-
tion. Such cells could be present and active in the ma-
ture lymphoid organs or might be developmentally reg-
ulated and absent from the mature tissue. With this
caveat, the studies reported here provide the strongest
evidence to date that TNF acts directly on FDC to
induce their clustering within the B cell follicle and to
activate their ability to support a functional GC re-
sponse. It will be of interest to extend this model to de-
termine whether the FDC clusters that form in tertiary
lymphoid nodules at sites of chronic inflammation,
which may be important in the tissue destruction asso-
ciated with this inflammation, are governed by the same
TNF stimuli.
Victoratos et al. used a similar approach to investi-
gate postreceptor signaling in the restoration of FDC
clustering and function. Previous studies have shown
that intracellular signaling molecules of the nuclear fac-
tor-kB (NF-kB) family mediate p55TNFR-induced acti-
vation of FDC. The classical NF-kB signaling pathway
acts through IKK2 and causes nuclear translocation of
p50:RelA heterodimers to activate genes involved in in-
flammation and innate immune responses, whereas the
alternative NF-kB pathway acts through the other ki-
nases IKK1 and NIK and causes nuclear translocation
of p52:RelB heterodimers to regulate genes that medi-
ate lymphotoxin-induced lymphoid organogenesis
and lymphoid tissue homeostasis (Figure 1). Mice with
IKK2 deficiency only in the radio-resistant FDCs were
prepared by CD21-Cre-driven targeting to ablate IKK2
expression in CD21+ cells followed by reconstitution
of IKK2 expression in B cells by transplantation with
normal bone marrow. These mice showed that IKK2-
deficient FDCs clustered in a fashion indistinguishable
from wild-type FDCs and also supported the formation
of morphologically normal GC. This observation sug-
gests that the classical NF-kB pathway is not required
for proper localization and clustering of FDCs. In con-
trast, although IKK2-deficient FDC could bind and retain
immune complexes in an apparently normal fashion,
they were unable to upregulate their cell-surface ex-
pression of ICAM-1 and VCAM-1 and could not support
the upregulation of AID and other activation-associated
factors in GC B cells (Victoratos et al., 2006). This defect
was associated with increased GC B cell apoptosis
and failure to generate a high-affinity, isotype-switched
antibody response. Thus, in FDCs, activation of the
p55TNFR induces IKK2-independent signals that sup-
port FDC clustering, localizing of immune complexes,and activation of B cell proliferation to form a morpho-
logical GC. Activation of the p55TNFR also induces
IKK2-dependent signals that support upregulation of
ICAM-1 and VCAM-1 expression, suppression of GC
B cell apoptosis, and expression of high-affinity anti-
bodies. With their dependence on the upregulation of
ICAM-1 and VCAM-1 expression, these activities may
represent p55TNFR-induced quasi-inflammatory re-
sponses, explaining their IKK2 dependence. Future ex-
periments analyzing the gene-expression profiles of
IKK2-expressing and IKK2-deficient FDCs will identify
key genes involved in the activation and function of
these cells in the GC response. Additional experiments
in which the expression of ICAM-1 and VCAM-1 is artifi-
cially maintained in the absence of IKK2 expression may
permit determination of the role of cell adhesion as
a driver of a productive GC reaction.
The experiments reported by Victoratos et al. have
unequivocally established FDCs as critical cells organ-
izing the B cell follicle and the mature GC response.
They also provide proof of principle that the strategies
of lineage-specific gene targeting and lineage-specific
gene repair can dissect complex issues of tissue func-
tion that are not accessible to standard biochemical
and molecular techniques.
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